HDAC1 and prostate carcinoma: Beside gastric cancer, the expression of miR-449 has also been found to be reduced in several cell lines [55] and in prostate cancer, where it was found to target HDAC1 and induce growth arrest following over-expression in prostate cancer cells [56].